BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37751032)

  • 1. Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.
    Wipplinger C; Cattaneo A; Wipplinger TM; Lamllari K; Semmler F; Geske C; Messinger J; Nickl V; Beez A; Ernestus RI; Pham M; Westermaier T; Weiland J; Stetter C; Kunze E
    Neurosurg Rev; 2023 Sep; 46(1):256. PubMed ID: 37751032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to editor: Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: A retrospective evaluation of a 12-year single-center experience.
    Sohail K; Zaidi SMF
    Neurosurg Rev; 2024 Apr; 47(1):193. PubMed ID: 38662220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm as well as Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Retrospective Matched Case-Control Analysis.
    Feulner J; Weidinger CS; Dörfler A; Birkholz T; Buchfelder M; Sommer B
    World Neurosurg; 2024 Jun; 186():e106-e113. PubMed ID: 38514031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2018 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
    Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
    Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
    Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.
    Takeuchi S; Kumagai K; Toyooka T; Otani N; Wada K; Mori K
    Stroke; 2021 Jan; 52(1):20-27. PubMed ID: 33349011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage.
    Dorhout Mees SM; van den Bergh WM; Algra A; Rinkel GJ
    J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):729-31. PubMed ID: 17135457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A letter to the editor: Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.
    Sun Y; Zhao H; An Y
    Neurosurg Rev; 2023 Oct; 46(1):273. PubMed ID: 37845559
    [No Abstract]   [Full Text] [Related]  

  • 14. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Ditz C; Matone MV; Schwachenwald B; Küchler J
    Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
    Chalet FX; Briasoulis O; Manalastas EJ; Talbot DA; Thompson JC; Macdonald RL
    Neurol Ther; 2023 Apr; 12(2):371-390. PubMed ID: 36609962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.
    Wong GK; Boet R; Poon WS; Chan MT; Gin T; Ng SC; Zee BC
    Crit Care; 2011; 15(1):R52. PubMed ID: 21299874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial-Doppler-Measured Vasospasm Severity is Associated with Delayed Cerebral Infarction After Subarachnoid Hemorrhage.
    Snider SB; Migdady I; LaRose SL; Mckeown ME; Regenhardt RW; Lai PMR; Vaitkevicius H; Du R
    Neurocrit Care; 2022 Jun; 36(3):815-821. PubMed ID: 34751900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium sulfate for aneurysmal subarachnoid hemorrhage: the end of the road or more trials?
    Vergouwen MD
    Crit Care; 2011; 15(2):140. PubMed ID: 21489317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
    van den Bergh WM; Algra A; van Kooten F; Dirven CM; van Gijn J; Vermeulen M; Rinkel GJ;
    Stroke; 2005 May; 36(5):1011-5. PubMed ID: 15790946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study.
    Muraoka S; Asai T; Fukui T; Ota S; Shimato S; Koketsu N; Nishizawa T; Araki Y; Saito R
    Neurosurg Rev; 2023 Aug; 46(1):195. PubMed ID: 37555872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.